Navigation Links
For Patients Who Fail on Viagra, Levitra or Cialis
Date:10/29/2008

TriMix Laboratories Announces Major Product Enhancement

CHERRY HILL, N.J., Oct. 29 /PRNewswire/ -- TriMix Laboratories LLC today announced a major enhancement to their flagship product TriMix-gel(TM). TriMix-gel(TM) uses the ED gel(TM) (pat. pend.) applicator system. The applicator has been fitted with an adapter to make the use of TriMix-gel(TM) even easier for the patient. The adapter will be included for shipment to patients immediately.

The new adapter is featured on the website http://www.trimixgel.com. A video there includes a demonstration of an actual patient applying the medicine. TriMix Laboratories President T.J. Harkins says, "The innovative nature of the TriMix-gel(TM) applicator makes it hard to describe in a small sound bite. This video is an important tool in helping ED patients understand how valuable TriMix-gel(TM) can be for them."

TriMix-gel(TM) has been used by doctors as an alternative erectile dysfunction (ED) treatment. Doctors prescribe TriMix-gel(TM) for patients who have failed on Viagra, Levitra or Cialis type tablets or who cannot tolerate their side effects. Trimix ingredients have been tested and widely prescribed for many years for improvement of sexual health.

TriMix-gel(TM) contains active ingredients which are classified as medicine and are listed in the US Pharmacopoeia. Therefore, a patient would need a prescription from his physician to obtain TriMix-gel(TM). For an order form, visit http://www.trimixgel.com and click the prescription form. The patient gives the form to the doctor. The doctor faxes the prescription to the pharmacy at 877-387-4649 and the pharmacy ships the medicine directly to the patient.

Typically, the trimix liquid for injection version of the compound would have to be refrigerated and then self injected with a needle at time of use. But the compound in gel form, called TriMix-gel(TM), allows the patient to carry the medicine at room temperature. More importantly, an ED patient will not have to use a needle to self inject before sexual intercourse.

Recently, clinical trials were performed on TriMix-gel(TM). All the test patients were men who failed on Viagra, Levitra or Cialis tablets. These patients were given TriMix-gel(TM). All the test patients received some degree of positive effect from TriMix-gel(TM) in the form of tumescence (enlargement). It was determined that 40% of the test patients achieved a result sufficient for sexual intercourse over Viagra, Levitra or Cialis tablets.

The trial results were published in the Journal of Urology Supplement, J. Urol. 179 (4): 431, 2008. For more information, visit http://www.trimixgel.com and click "Drug Studies."

TriMix Laboratories President T.J. Harkins said, "Our test patients were very impressed with the 'ease of use.' We are happy our new adapter is so well received."

TriMix Laboratories LLC is a medical research and marketing firm specializing in the urological subspecialty of erectile dysfunction. The information contained herein is general in nature and is intended for use only as an informational aid. It does not cover all possible uses, actions, precautions, side effects, or interactions of the products shown, nor is the information intended as medical advice or diagnosis for individual health problems. TriMix-gel(TM) has not been evaluated by the Food and Drug Administration ("FDA"). TriMix-gel(TM) is not made under GMP requirements. It is compounded in a licensed compounding pharmacy for the use of an individual patient who has been prescribed TriMix-gel(TM) by a licensed physician. It is not intended for making an evaluation as to the risks and benefits. Before taking any action, consult your Doctor.

Contact: T.J. Harkins

TriMix Laboratories

Cherry Hill, NJ

856-428-7008


'/>"/>
SOURCE TriMix Laboratories LLC
Copyright©2008 PR Newswire.
All rights reserved

Related medicine news :

1. Fluctuating eye pressure associated with visual field deterioration in glaucoma patients
2. Comparison of obstetric outcomes between on-call and patients own obstetricians
3. Vision restoration therapy shown to improve brain activity in brain injured patients
4. Diabetes appears to increase risk of death for patients with acute coronary syndromes
5. Ambulatory oxygen rarely a benefit in COPD patients without resting hypoxemia
6. Restricting Blood Flow May Help Heart Bypass Patients
7. Patients with Medicaid and those lacking insurance have higher risk of advanced laryngeal cancer
8. Study provides hope that some transplant patients could live free of antirejection drugs
9. Study provides hope that some transplant patients could live free of anti-rejection drugs
10. Longer ambulance journeys boost death risk for seriously ill patients
11. Expenses Overshadow Optimism for Kidney Failure Patients
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:4/29/2017)... ... , ... More than half of Americans suffering from noise-induced hearing loss do ... that causes hearing loss? May 1 marks the beginning of Better Hearing & Speech ... well as schedule a hearing evaluation for anyone with concerns about his/her hearing. , ...
(Date:4/28/2017)... ... ... April 24th article on Yahoo! Beauty discusses the case of Jessica Weber, an ... loss surgery. The woman, declaring “I will not hate my body anymore!” posted pictures on ... loss. Dr. Feiz & Associates notes that, while it often refers its patients to a ...
(Date:4/28/2017)... ... April 28, 2017 , ... Accreditation ... the Home Care Association of America (HCAOA). This agreement allows HCAOA members to ... as well as discounts on Accreditation University (AU) educational resources that help prepare ...
(Date:4/28/2017)... Clara, CA (PRWEB) , ... April 28, 2017 ... ... is pleased to announce the integration of Microsoft(R) Word(TM) Online(TM), which enables sleep ... user experience, since it streamlines the reporting process and provides a familiar interface ...
(Date:4/28/2017)... ... 2017 , ... Horizon Blue Cross Blue Shield of New Jersey (BCBSNJ) announced ... its outlook as “stable.” At the same time, the ratings agency cautioned that the ... dip below “capital adequacy” thresholds required for its strong rating. , “Horizon is committed ...
Breaking Medicine News(10 mins):
(Date:4/20/2017)... , April 20, 2017  Vivify Health, the pioneer ... has been awarded a very significant patent for the ... to continual care via digital health.  This landmark patent ... property and further secures Vivify,s position as the leader ... 2009, was the first company to apply consumer mobile ...
(Date:4/20/2017)... Research and Markets has announced the addition of the ... Market and Increasing Usage of Complex Biologics during the Forecast Period" ... ... 20 Billion in 2015 to around USD 26 Billion by 2020. ... by Rapidly Expanding Injectables Market and Increasing Usage of Complex Biologics ...
(Date:4/20/2017)... , April 20, 2017 Research ... Pharmacogenomics Market Size, Market Share, Application Analysis, Regional Outlook, Growth ... report to their offering. ... The global pharmacogenomics market was valued at US$ 7,167.6 ... Mn by 2024, expanding at a CAGR of 5.6% from ...
Breaking Medicine Technology: